Personal Genome Diagnostics (PGDx)

Our mission is to empower personalized care by providing rapid precision oncology diagnostics to all patients.

[Personal Genome Diagnostics (PGDx) @PGDx_]

Hot of the press: Our new publication featured in @NatureComms highlights how the @US_FDA -cleared elio™ tissue complete assay is a viable solution to bring the promise of #precisiononcology to patients with cancer. https://t.co/9VJThjgxZS

[Personal Genome Diagnostics (PGDx) @PGDx_]

The Labcorp Oncology team enjoyed our discussions at #AMP2022 this year. Thank you for stopping by to see our exhibit and attending our workshops highlighting the real-world customer experience of our kitted solutions that are helping to expedite cancer care.

[Personal Genome Diagnostics (PGDx) @PGDx_]

Don't miss the webinar "Impact of Genomic Profiling on Risk Stratification and Treatment Selection in Acute Myeloid Leukemia" on Tuesday, November 29 at 1pm EST. Panelists will review clinical cases and host a Q&A. Register today: https://t.co/sCb2qWqRyq #precisiononcology #AML

[Eric Severson @ESeversonMDPhD]

Great turn out today at our @AMPath workshop today @AMPath. We reviewed how a simple blood draw from a patient with cancer can become genomic data and inform #precisiononcology. @PGDx @Labcorp #AMPath22 #AMPlifier

[Personal Genome Diagnostics (PGDx) @PGDx_]

Don't miss the webinar "Impact of Structural Variants and Co-Occurring Variants on Cancer Therapy Prioritization" on Tuesday, November 15 at 1pm EST. Panelists will review patient cases and host a Q&A. Register today: https://t.co/eA9YFHIi2k #precisiononcology

[Personal Genome Diagnostics (PGDx) @PGDx_]

Join us for the "Therapeutic Case for Expanding Germline Cancer Risk Panels: Implications for HRD and Beyond" webinar on Tuesday, Nov. 1 at 1 p.m. EST. Panelists will review clinical cases and host a live Q&A. Register today: https://t.co/qLWQJ9Riz8 #precisiononcology #cancercare

[Personal Genome Diagnostics (PGDx) @PGDx_]

Are you attending #AMP2022? Join our free workshops to learn how we are helping to democratize access to precision oncology for patients with cancer. Register here to save your seat and have a chance to win a door prize. https://t.co/3GgSzjQ35H

[Personal Genome Diagnostics (PGDx) @PGDx_]

The co-approval of HER2 monoclonal antibody therapeutics and CDx raised the bar for #breastcancer therapies. Since then, we have been closely associated with pivotal studies in breast cancer with CDK4/6 and PARP inhibitors and biomarkers. https://t.co/hBE4rsq2Ti

[Personal Genome Diagnostics (PGDx) @PGDx_]

The Countdown for #AMP2022 has begun! We look forward to meeting you in person in Phoenix, AZ. Come to booth 1102 to discover how we are helping to deliver the promise of precision medicine to all patients. https://t.co/K3St0rQ52K

[Personal Genome Diagnostics (PGDx) @PGDx_]

Join us for the "Therapeutic Case for Expanding Germline Cancer Risk Panels: Implications for HRD and Beyond" webinar on Tuesday, Nov. 1 at 1 p.m. EST. Panelists will review clinical cases and host a live Q&A. Register today: https://t.co/0Dnb1dFavG #precisiononcology #cancercare

[Personal Genome Diagnostics (PGDx) @PGDx_]

PGDx is now part of @Labcorp. Be sure to follow Labcorp to stay up-to-date on the latest #oncology updates. We look forward to providing timely and relevant information about how we are driving precision cancer care forward: https://t.co/k3UG7hZoXL

[Personal Genome Diagnostics (PGDx) @PGDx_]

October is breast cancer awareness month. From a single breast biopsy, OmniSeq INSIGHT® can help oncologists identify targeted treatment options for patients with breast cancer. https://t.co/WkdVBhMTar #BreastCancerAwarenessMonth

[Personal Genome Diagnostics (PGDx) @PGDx_]

Join us for the "Multiomic Analyses and Cancer Therapy Selection" webinar on Tuesday, Oct. 18 at 1 p.m. EST. Panelists will review patient cases and host a live Q&A. Register today: https://t.co/59UmhOGx7T
#precisiononcology #biomarkers

[Labcorp @Labcorp]

Thank you to the many #oncology scientists who showcased the breadth and depth of our clinical diagnostics and research innovations at the Labcorp R&D Summit.

The Summit is a time for scientists and leaders from across the company to share highlights of their work.

[Labcorp @Labcorp]

Dr. Prasanth Reddy, SVP and Global Head of Enterprise Oncology, recently shared his views on how Labcorp is working with cancer care teams, biopharma partners, and patients to improve outcomes through innovations in science, real world data and patient access. #precisiononcology

[Labcorp @Labcorp]

Over 1.5 million people in the U.S. are living with or in remission from #leukemia, #lymphoma, #myeloma, #MDS or #MPN. Labcorp Oncology is dedicated to assisting cancer care teams to diagnose and treat their patients' living with #bloodcancers. https://t.co/XyQuZ5Ot3m

[Labcorp @Labcorp]

Chairman and CEO @AdamHSchechter has been nominated for @modrnhealthcr's 100 Most Influential People in Healthcare award.

We encourage you to vote to show your support for Adam's leadership as we work to improve health and improve lives. https://t.co/sFcX8qS2W2 #MH100Most

[Labcorp @Labcorp]

It is estimated 15,950 children and adolescents will be diagnosed with cancer this year. During #ChildhoodCancerAwareness month, we commend those who dedicate their lives to patients in need.

Get to know our pediatric and other #oncology teams: https://t.co/8fmqmSbVDE

[Labcorp @Labcorp]

We’re dedicated to helping providers improve access to healthcare through new diagnostic tools. With liquid biopsy, providers have an easier way to access the #cancer genomic profile than ever before. https://t.co/XU9wmzkasz
Produced by WIRED Brand Lab with Labcorp
#oncology